Gastroenterology (GI) has approximately 3,000 referrals waiting to be scheduled, with limited appointment slots available to see new patients. This means nonurgent general GI referrals without red flags, including constipation (which is one of the more common referrals received by GI), are currently scheduling three to five months out.
While GI is continuing to accept patient referrals for constipation at this time, program leaders are encouraging PCPs to manage their patients with constipation in primary care whenever possible and appropriate to ensure the most timely care. This also helps Seattle Children’s maintain access for patients who most need specialty care.
To assist PCPs in caring for patients with constipation, Seattle Children’s offers a detailed functional constipation clinical protocol and algorithm on our website. In addition, the GI Refer a Patient webpage offers:
Patients with constipation who have red flags (see protocol and/or algorithm) or who have attempted the treatment protocol without success are appropriate to be seen by GI and should be referred. Please clearly describe the treatment that has been tried already to help us properly triage and schedule your patient.
The Seattle Children’s GI team acknowledges the excellent work of PCPs in the community who are managing constipation in primary care and encourage you to let us know if there are ways we can improve the resources we are providing (above) in support of your care.
Hospital capacity
Seattle Children’s is beginning to experience some relief from the extremely high capacity constraints of recent months. We do, however, continue to see high winter volumes.
- Overall hospital census remains high, and the Emergency Department (ED) is still seeing extremely high patient volumes.
- The wave of patients experiencing mental and behavioral health crises is not slowing down.
- Seattle Children’s remains in active Code Yellow status, although at a lower level of response; we continue to monitor the situation and enact solutions to address the challenges we are facing.
Other important updates from Seattle Children’s
- Synagis season has ended: Due to exponential declines in RSV rates and related admissions, Seattle Children’s is no longer administering Synagis prophylaxis as of Tuesday, February 28. For more information, please consult state-specific recommendations for patients outside of our local area and review WA state and other data from the CDC.
- We have a scheduling backlog; please encourage families to proactively call us to schedule. We are hiring additional scheduling staff to keep pace with high demand but our pace of calling out to families to schedule is slower than we’d like. In some cases, patients may get an appointment several weeks sooner if they proactively call us to schedule instead of waiting for one of our schedulers to call them.
- GI has high referral volumes and long wait times; please manage constipation in primary care whenever possible.
- Non-urgent general GI referrals without red flags, including constipation, are currently scheduling 3 to 5 months out.
- GI has approximately 3,000 referrals in their scheduling queue with limited slots immediately available.
- GI is still accepting constipation referrals but encourages PCPs to see these patients in primary care whenever possible to ensure timely care. This will also help Seattle Children’s maintain good access for patients who most need specialty care.
- Our GI Refer a Patient webpage offers many PCP resources including:
Evelyn Hsu
Seattle Children’s is pleased to announce that Dr. Evelyn Hsu accepted the position of division chief of Gastroenterology and Hepatology, following a year as acting division chief and a very competitive national search. She also has served as program director of the Transplant Hepatology Fellowship and medical director for Liver Transplantation.
“I’m excited to join this group in an official capacity. My priority is to expand our staff and open up our services to care for more children in our region, while implementing a service model that allows us to scale up in size while continuing to provide excellent care.,” says Hsu. Read full post »
The Intestinal Rehabilitation Program at Seattle Children’s, the only program of its kind in the Pacific Northwest, is dedicated to reducing transplantation rates through innovative research that improves intestinal failure management.
Seattle Children’s was one of the largest recruiters for the first 12-week trial evaluating the efficacy and safety of the investigational drug teduglutide for patients with long-term TPN dependence related to short bowel syndrome. Already approved for short bowel syndrome treatment in adults, teduglutide is designed to reduce the need for TPN.
“Teduglutide is the first drug to be introduced to the commercial market that has a sound theoretical basis, as well as supportive preclinical and adult clinical studies, to improve intestinal adaptation above and beyond what can be achieved with the best standard of care,” says Dr. Simon P. Horslen, director of the Intestinal Rehabilitation Program and medical director of Solid Organ Transplantation at Seattle Children’s, and professor of pediatrics with UW Medicine. “Anything that has the potential to wean a child from TPN or even reduce the amount of TPN they receive will improve quality of life.”
Results from the initial 12-week trial were promising. Among 42 children ages 1 to 17, the treatment was associated with overall reductions in TPN, in some cases as significant as 41%. Four children were weaned from TPN entirely during the study.
Horslen and his co-investigator, Dr. Danielle Wendel, gastroenterologist at Seattle Children’s and assistant professor at UW Medicine, are awaiting results from a recently completed 24-week study.
“Teduglutide is a huge step forward in the management of intestinal failure,” Horslen says. Read full post »
At Seattle Children’s, the Pacific Northwest’s only dedicated pediatric hepatologists are actively engaged in research consortiums and working to improve treatments for pediatric liver diseases.
Two of these physicians, Dr. Evelyn K. Hsu, program director of the Advanced/Transplant Hepatology Fellowship at UW Medicine and Seattle Children’s, and Dr. Karen F. Murray have spearheaded a number of innovative studies that have improved children’s access to lifesaving transplants and medications. Read full post »
A Q&A with Dr. Dale Lee
Seattle Children’s recently launched a new Celiac Disease Program within its Gastroenterology Division. This program gives patients access to physicians and registered dietitians specially trained and experienced in working with pediatric patients with celiac disease.
Dr. Dale Lee, director of the Celiac Disease Program, addresses questions related to celiac disease, the new program and services it offers.
Thank you to Dr. Wendy Sue Swanson, a pediatrician at The Everett Clinic in Mill Creek, a member of Seattle Children’s medical staff and executive director of Digital Health, and author of the Seattle Mama Doc blog, for submitting these questions.
There is certainly public interest in gluten-free diets. Help us put in context those who seem to feel healthier and happier off gluten, and those who must be off gluten.
Gluten is commonplace in our modern diet and individuals can have a variety of conditions related to gluten.
- Celiac disease is an immune-mediated hypersensitivity to gluten that results in intestinal inflammation/damage that can occur in certain genetically susceptible individuals.
- Wheat allergy is different than celiac disease, but is also immune-mediated and can result in a variety of symptoms including rash, abdominal pain, vomiting or breathing difficulties.
- Non-celiac gluten sensitivity (also referred to as “gluten intolerance”) does not involve an immunological response, but the symptoms can be similar to celiac disease, such as abdominal pain, vomiting or diarrhea.
Read full post »
